John M. Maraganore
2009
In 2009, John M. Maraganore earned a total compensation of $1.5M as Chief Executive Officer at Alnylam Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $86,625 |
---|---|
Option Awards | $924,483 |
Salary | $525,000 |
Other | $11,288 |
Total | $1,547,396 |
Maraganore received $924.5K in option awards, accounting for 60% of the total pay in 2009.
Maraganore also received $86.6K in non-equity incentive plan, $525K in salary and $11.3K in other compensation.
Rankings
In 2009, John M. Maraganore's compensation ranked 3,086th out of 9,885 executives tracked by ExecPay. In other words, Maraganore earned more than 68.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,086 | 69th |
Manufacturing | 1,080 | 71st |
Chemicals And Allied Products | 211 | 76th |
Drugs | 122 | 81st |
Pharmaceutical Preparations | 99 | 78th |
Maraganore's colleagues
We found four more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2009.
2009
Barry Greene
Alnylam Pharmaceuticals
Chief Operating Officer
2009
Akshay Vaishnaw
Alnylam Pharmaceuticals
Senior Vice President, Clinical Research
2009
John Schmidt
Alnylam Pharmaceuticals
Chief Scientific Officer
2009
Patricia Allen
Alnylam Pharmaceuticals